- Home
- A
as 07-26-2024 4:00pm EST
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 44.2B | IPO Year: | 1999 |
| Target Price: | $137.13 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.22 | EPS Growth: | -7.25 |
| 52 Week Low/High: | $96.80 - $155.35 | Next Earning Date: | 08-21-2024 |
| Revenue: | $6,591,000,000 | Revenue Growth: | -6.38% |
| Revenue Growth (this year): | -3.28% | Revenue Growth (next year): | 5.57% |
Stock Insider Trading Activity of Agilent Technologies Inc. (A)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MCDONNELL PADRAIG | A | President and CEO | Jun 18 '24 | Sell | $135.00 | 1,958 | $264,330.00 | 28,034 | SEC Form 4 |
| MCDONNELL PADRAIG | A | President and CEO | Jun 3 '24 | Sell | $130.00 | 1,958 | $254,540.00 | 25,185 | SEC Form 4 |
| Binns Philip | A | Senior Vice President | Mar 25 '24 | Sell | $147.54 | 2,827 | $417,095.58 | 9,997 | SEC Form 4 |
| Binns Philip | A | Senior Vice President | Dec 27 '23 | Sell | $139.78 | 2,880 | $402,566.40 | 12,824 | SEC Form 4 |
Latest Agilent Technologies Inc. News
A Breaking Stock News: Dive into A Ticker-Specific Updates for Smart Investing
Insider Monkey
4 hours ago
Agilent Technologies, Inc. (A): Hedge Funds Are Bullish on This Scientific Instruments Stock Now
Exec Edge
a day ago
Agilent to Acquire Canadian CDMO BIOVECTRA for $925 Million
BioPharma Dive
3 days ago
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
Argus Research
3 days ago
A: Lowering target price to $137.00
Simply Wall St.
3 days ago
Estimating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Pharmaceutical Technology
4 days ago
Agilent agrees to acquire BIOVECTRA for $925m
Zacks
4 days ago
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
Reuters
4 days ago
Agilent to buy contract drug manufacturer Biovectra for $925 million
Compare A vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "A Agilent Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.